Q2 2024 EPS Estimates for Henry Schein, Inc. (NASDAQ:HSIC) Boosted by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Zacks Research lifted their Q2 2024 earnings estimates for Henry Schein in a research report issued to clients and investors on Wednesday, May 1st. Zacks Research analyst U. Biswas now expects that the company will earn $1.27 per share for the quarter, up from their previous forecast of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Zacks Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.34 EPS.

Other equities research analysts have also issued research reports about the stock. SVB Leerink assumed coverage on shares of Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target on the stock. Jefferies Financial Group raised their price target on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. Barrington Research raised their price target on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, February 28th. Finally, Piper Sandler raised their price objective on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus price target of $81.09.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $67.78 on Monday. The firm’s 50 day moving average is $73.46 and its two-hundred day moving average is $72.32. Henry Schein has a 52 week low of $60.01 and a 52 week high of $82.63. The firm has a market capitalization of $8.71 billion, a P/E ratio of 21.52, a PEG ratio of 1.68 and a beta of 0.87. The company has a current ratio of 1.67, a quick ratio of 1.00 and a debt-to-equity ratio of 0.45.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.70 by ($0.04). The business had revenue of $3.02 billion for the quarter, compared to analyst estimates of $3 billion. Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. Henry Schein’s revenue was down 10.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.21 EPS.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Pzena Investment Management LLC boosted its stake in Henry Schein by 22.2% in the 1st quarter. Pzena Investment Management LLC now owns 989,671 shares of the company’s stock worth $74,740,000 after purchasing an additional 180,113 shares during the period. Banyan Capital Management Inc. acquired a new stake in shares of Henry Schein during the 1st quarter valued at $5,867,000. Central Pacific Bank Trust Division acquired a new stake in shares of Henry Schein during the 1st quarter valued at $914,000. FORA Capital LLC acquired a new stake in shares of Henry Schein during the 1st quarter valued at $1,816,000. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Henry Schein by 11.0% during the 1st quarter. Daiwa Securities Group Inc. now owns 12,869 shares of the company’s stock valued at $972,000 after buying an additional 1,279 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Insider Buying and Selling

In related news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now directly owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the transaction, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.